188 related articles for article (PubMed ID: 24849041)
41. Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model.
Holohan DR; Van Gool F; Bluestone JA
PLoS One; 2019; 14(10):e0217728. PubMed ID: 31647813
[TBL] [Abstract][Full Text] [Related]
42. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
[TBL] [Abstract][Full Text] [Related]
43. Diabetes is not prevented by Foxp3-transduced CD4(+)T cells under the IL-12Rbeta2 promoter control.
Wang R; Han G; Wang J; Song L; Chen G; Xu R; Wang L; Li X; Shen B; Li Y
Mol Immunol; 2008 Aug; 45(14):3814-7. PubMed ID: 18599122
[TBL] [Abstract][Full Text] [Related]
44. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
[TBL] [Abstract][Full Text] [Related]
45. Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice.
Hu CM; Lin HH; Chiang MT; Chang PF; Chau LY
Diabetes; 2007 May; 56(5):1240-7. PubMed ID: 17303808
[TBL] [Abstract][Full Text] [Related]
46. Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells.
Kaminitz A; Mizrahi K; Yaniv I; Stein J; Askenasy N
J Autoimmun; 2010 Sep; 35(2):145-52. PubMed ID: 20638242
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-33 prevents the development of autoimmune diabetes in NOD mice.
Lu J; Liang Y; Zhao J; Meng H; Zhang X
Int Immunopharmacol; 2019 May; 70():9-15. PubMed ID: 30780005
[TBL] [Abstract][Full Text] [Related]
48. Reduced interleukin-2 responsiveness impairs the ability of Treg cells to compete for IL-2 in nonobese diabetic mice.
James CR; Buckle I; Muscate F; Otsuka M; Nakao M; Oon JSh; Steptoe RJ; Thomas R; Hamilton-Williams EE
Immunol Cell Biol; 2016 May; 94(5):509-19. PubMed ID: 26763864
[TBL] [Abstract][Full Text] [Related]
49. Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes.
Kerkvliet NI; Steppan LB; Vorachek W; Oda S; Farrer D; Wong CP; Pham D; Mourich DV
Immunotherapy; 2009 Jul; 1(4):539-47. PubMed ID: 20174617
[TBL] [Abstract][Full Text] [Related]
50. Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice.
Mattner J; Mohammed JP; Fusakio ME; Giessler C; Hackstein CP; Opoka R; Wrage M; Schey R; Clark J; Fraser HI; Rainbow DB; Wicker LS
PLoS Genet; 2019 Jun; 15(6):e1008178. PubMed ID: 31199784
[TBL] [Abstract][Full Text] [Related]
51. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.
Madec AM; Mallone R; Afonso G; Abou Mrad E; Mesnier A; Eljaafari A; Thivolet C
Diabetologia; 2009 Jul; 52(7):1391-9. PubMed ID: 19421731
[TBL] [Abstract][Full Text] [Related]
52. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
[TBL] [Abstract][Full Text] [Related]
53. Marked dendritic cell-T cell cluster formation in the pancreatic lymph node of the non-obese diabetic mouse.
Clare-Salzler M; Mullen Y
Immunology; 1992 Jul; 76(3):478-84. PubMed ID: 1356097
[TBL] [Abstract][Full Text] [Related]
54. Gene Therapy with an Adeno-Associated Viral Vector Expressing Human Interleukin-2 Alters Immune System Homeostasis in Humanized Mice.
Durost PA; Aryee KE; Manzoor F; Tisch RM; Mueller C; Jurczyk A; Shultz LD; Brehm MA
Hum Gene Ther; 2018 Mar; 29(3):352-365. PubMed ID: 28826231
[TBL] [Abstract][Full Text] [Related]
55. Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice.
Dwyer CJ; Bayer AL; Fotino C; Yu L; Cabello-Kindelan C; Ward NC; Toomer KH; Chen Z; Malek TR
Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259102
[TBL] [Abstract][Full Text] [Related]
56. Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice.
Lu Y; Tang M; Wasserfall C; Kou Z; Campbell-Thompson M; Gardemann T; Crawford J; Atkinson M; Song S
Hum Gene Ther; 2006 Jun; 17(6):625-34. PubMed ID: 16776571
[TBL] [Abstract][Full Text] [Related]
57. IL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetes.
Diaz-de-Durana Y; Lau J; Knee D; Filippi C; Londei M; McNamara P; Nasoff M; DiDonato M; Glynne R; Herman AE
PLoS One; 2013; 8(10):e78483. PubMed ID: 24205242
[TBL] [Abstract][Full Text] [Related]
58. TLR2- and Dectin 1-associated innate immune response modulates T-cell response to pancreatic β-cell antigen and prevents type 1 diabetes.
Karumuthil-Melethil S; Sofi MH; Gudi R; Johnson BM; Perez N; Vasu C
Diabetes; 2015 Apr; 64(4):1341-57. PubMed ID: 25377877
[TBL] [Abstract][Full Text] [Related]
59. Gut Microbiota-Stimulated Innate Lymphoid Cells Support β-Defensin 14 Expression in Pancreatic Endocrine Cells, Preventing Autoimmune Diabetes.
Miani M; Le Naour J; Waeckel-Enée E; Verma SC; Straube M; Emond P; Ryffel B; van Endert P; Sokol H; Diana J
Cell Metab; 2018 Oct; 28(4):557-572.e6. PubMed ID: 30017352
[TBL] [Abstract][Full Text] [Related]
60. T Regulatory Cells From Non-obese Diabetic Mice Show Low Responsiveness to IL-2 Stimulation and Exhibit Differential Expression of Anergy-Related and Ubiquitination Factors.
Godoy GJ; Olivera C; Paira DA; Salazar FC; Ana Y; Stempin CC; Motrich RD; Rivero VE
Front Immunol; 2019; 10():2665. PubMed ID: 31824482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
